Canaan Partners IX LLC, Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 27,460 shares at $11.03 ($303K) on 2016-11-09, disclosed to the SEC on 2016-11-10.
Open-market sale of $303k CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.03 | 13,730 | $151K | 50.0% |
| 2 | $11.03 | 13,730 | $151K | 50.0% |
| Total | $11.03 avg | 27,460 | $303K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-21 | $526K | — | Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-06-10 | $487K | — | Filing → |